Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01555879 · ClinicalTrials.gov registry record
Real-world Clinical Efficacy of Abatacept in the T3 Data Registry
A clinical trial of Arthritis, Rheumatoid, sponsored by Arthritis Northwest P.
- Completed
- Registry status
- 200
- Enrollment target
- 1
- Study location
NCT01555879: Completed study of Arthritis, Rheumatoid, sponsored by Arthritis Northwest P.
NCT01555879 is a study of Arthritis, Rheumatoid that has completed, run by Arthritis Northwest P. The registered enrollment target is 200 participants, below the 634-participant average among 27 other Arthritis, Rheumatoid trials with a reported enrollment target (68% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01555879, a study of Arthritis, Rheumatoid, has completed, sponsored by Arthritis Northwest P.
- COMPLETED
- Registry status
- 200 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to assess the effectiveness of Abatacept in real-world clinical practice. The main hypothesis to be examined in this study is, "Abatacept's effectiveness results in a single real-world clinic (n = 100) are reproducible at another site (n \~= 200)".
Conditions Studied
Interventions
- DRUG Abatacept
Study Locations (1)
Washington
- Arthritis Northwest - Spokane
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 200 participants |
| Start Date | 2012-03 |
| Est. Completion | 2016-11 |
What the finished NCT01555879 record still lists
NCT01555879 is an observational study that tracks outcomes without assigning an intervention. The registered 200 participants enrollment target is mid-sized for trials with a published cap, below the 634-participant average among 27 other Arthritis, Rheumatoid trials with a reported enrollment target (68% lower).
The record links to 1 condition, with Arthritis, Rheumatoid appearing as the primary indexed condition, and to 1 intervention - of which Abatacept is the first listed.
NCT01555879 reports a single indexed study location in Washington.
Frequently Asked Questions
What is clinical trial NCT01555879 about?
NCT01555879 is a clinical study titled "Real-world Clinical Efficacy of Abatacept in the T3 Data Registry". The purpose of this study is to assess the effectiveness of Abatacept in real-world clinical practice. The main hypothesis to be examined in this study is, "Abatacept's effectiveness results in a single real-world clinic (n = 100) are reproducible at another site (n \~= 200)".
What is the current status of trial NCT01555879?
This trial is currently completed. The enrollment target is 200 participants. The study started on 2012-03. Estimated completion is 2016-11.
What conditions does trial NCT01555879 study?
This clinical trial studies the following conditions: Arthritis, Rheumatoid.
What interventions are being tested in trial NCT01555879?
The interventions under investigation include: Abatacept (DRUG).
Who is sponsoring clinical trial NCT01555879?
This trial is sponsored by Arthritis Northwest P, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01555879 being conducted?
This trial has 1 study location across Washington. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Arthritis, Rheumatoid
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01555879's enrollment target sits among peer trials
200 16th of 27 higher than 11 of 27 other Arthritis, Rheumatoid trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Arthritis, Rheumatoid trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Chronic Pain in Rheumatoid Arthritis
RECRUITING
-
R-2487 in Patients With Rheumatoid Arthritis
RECRUITING · Phase 1
-
IMPACT - AndHealth Autoimmune Research Registry
RECRUITING
-
A Clinical Study of Tulisokibart (MK-7240) to Treat Rheumatoid Arthritis (RA) (MK-7240-014)
RECRUITING · Phase 2
-
Laser-based Photoacoustic Tomography of Human Inflammatory Arthritis
RECRUITING
-
INFINITY™ With ADAPTIS™ Technology Study
ACTIVE NOT RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00107289 · 200 participants · Phase 2
Iodine I 131 Metaiodobenzylguanidine in Treating Patients With Recurrent, Progressive, or Refractory Neuroblastoma or Malignant Pheochromocytoma or Paraganglioma
- NCT00109174 · 200 participants · NA
MRS Measurement of Glutamate and GABA Metabolism in Brain
- NCT00177268 · 200 participants
Blood, Urine, and Tissue Collection for Cutaneous Lymphoma, Eczema, and Atopic Dermatitis Research
- NCT00493688 · 200 participants
A Study to Determine Whether Perioperative Energy Dynamics Correlates With Postoperative Outcomes
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia